Provider & nursing perspectives on the “panculture”: opportunities for innovative diagnostic stewardship interventions - ...

Artificial intelligence-powered rare disease diagnostics firm 3billion Inc. debuted on the tech-heavy Kosdaq board of the Korea Exchange Nov. 14 with its IPO raising about ₩14.4 billion (US$10.25 ...

It is time to stop decades of failure . We have a lot to do to EndTB by 2030, said Professor (Dr) Guy Marks, President of the ...

Diversified healthcare REIT Assura will list on the main board of the JSE next week, wit the group looking to attract local ...

The manuscript was released online ahead of publication in The Journal of Molecular Diagnostics. AMP convened a SARS-CoV-2 Whole Genome Sequencing Working ... Through the efforts of its board of ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Good morning, and welcome to the Lucid Diagnostics Third Quarter ...

The FDA has approved the investigational new drug application of AS1986NS for prostate cancer detection and treatment.

Rhythm Biosciences Ltd. (AU:RHY) has released an update. Rhythm Biosciences Ltd has appointed Gavin Fox-Smith, a seasoned leader in the MedTech ...

IO-Link actuator board Demonstrates IO-Link transceiver and low-side power switch combination STMicroelectronics (NYSE:STM)<p ...

The Board of Directors of SciBase Holding AB (publ) ("SciBase" or the "Company") has today decided to carry out a capital raise totaling approximately ...

Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the third quarter ending September 30, 2024. “Our third-quarter results came ...